Randol R. Spaulding

Biography

Randol R. Spaulding founded Spaulding Clinical Pharmacology and Spaulding Properties. At present, Spaulding Clinical Pharmacology has over 100 employees and boasts the most technologically advanced, fully-automated Research Unit with data quality unmatched by competitors. While establishing the Clinical Pharmacology unit, Randy seized the opportunity to further enhance clinical research by designing a new ECG device. In 2010, he opened Spaulding Core Labs, a Cardiac Safety testing center for new drugs under development. With the launch of the Spaulding Electrocardiograph in 2011 – Spaulding Clinicals handheld, proprietary ECG device – the company quickly caught global attention. Spaulding Medical was formed in 2012, taking this leading ECG technology into the healthcare market. Between all business units, Randy employs over 140 people and is driving year-over-year growth at a rate of 300%. In 2012 he was named “CEO of the Year” for Southeastern Wisconsin, in 2011 named provider of “Best Company Direction,” and Spaulding Clinical was acclaimed as a “Top 5 Workplace” for 2011 and 2012.

Research Interest

Clinical Pharmacology